Near-infrared fluorescence imaging tool with large Stokes shift for sensitively detecting carboxylesterase 2 and monitoring its expression in non-alcoholic fatty liver disease
Authors:
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Integrated multi-omic analysis identifies fatty acid binding protein 4 as a biomarker and therapeutic target of ischemia–reperfusion injury in steatotic liver transplantationCellular and Molecular Life Sciences, 2024
- Emerging role of carboxylesterases in nonalcoholic fatty liver diseaseBiochemical Pharmacology, 2022
- Burden of obesity in gastrointestinal and liver diseasesUnited European Gastroenterology Journal, 2022
- A highly sensitive and selective enzyme activated fluorescent probe for in vivo profiling of carboxylesterase 2Analytica Chimica Acta, 2022
- Mechanisms and disease consequences of nonalcoholic fatty liver diseaseCell, 2021
- Intestine‐Specific Overexpression of Carboxylesterase 2c Protects Mice From Diet‐Induced Liver Steatosis and ObesityHepatology Communications, 2018
- Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lungBiochemical Pharmacology, 2018
- Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver diseaseHepatology, 2016
- Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in miceHepatology, 2016
- A highly selective fluorescent ESIPT probe for the detection of Human carboxylesterase 2 and its biological applicationsBiosensors and Bioelectronics, 2015